US Stock MarketDetailed Quotes

OS Therapies (OSTX)

Watchlist
  • 1.770
  • +0.320+22.07%
Close Apr 24 16:00 ET
  • 1.770
  • 0.0000.00%
Post 19:59 ET
74.41MMarket Cap-1.81P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

OS Therapies (OSTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
321.28%28.71M
304.12%11.99M
182.25%6.88M
520.51%4.84M
693.28%5M
56.91%6.81M
156.38%2.97M
291.73%2.44M
-48.54%779.8K
-39.87%630.23K
Selling and administrative expenses
210.58%12.34M
52.25%3.19M
154.59%3.12M
510.39%2.34M
1,274.82%3.69M
253.09%3.97M
1,418.42%2.1M
631.76%1.23M
-26.65%383.23K
-8.78%268.42K
-General and administrative expense
210.58%12.34M
52.25%3.19M
154.59%3.12M
510.39%2.34M
1,274.82%3.69M
253.09%3.97M
1,418.42%2.1M
631.76%1.23M
-26.65%383.23K
-8.78%268.42K
Research and development costs
476.27%16.36M
910.57%8.8M
210.30%3.76M
530.28%2.5M
261.84%1.31M
-11.75%2.84M
-14.58%870.47K
166.27%1.21M
-60.06%396.57K
-52.00%361.81K
Operating profit
-321.28%-28.71M
-304.12%-11.99M
-182.25%-6.88M
-520.51%-4.84M
-693.28%-5M
-56.91%-6.81M
-156.38%-2.97M
-291.73%-2.44M
48.54%-779.8K
39.87%-630.23K
Net non-operating interest income expense
100.01%249
100.71%54
100.01%65
100.01%64
100.01%66
40.51%-2.05M
97.54%-7.56K
67.63%-437.84K
21.42%-777.68K
-3.73%-828.76K
Non-operating interest income
--249
5,500.00%54
--65
6,300.00%64
--66
--0
---1
--0
--1
--0
Non-operating interest expense
--0
--0
--0
--0
--0
-40.51%2.05M
-97.54%7.56K
-67.63%437.84K
-21.42%777.68K
3.73%828.76K
Other net income (expense)
-180.48%-48.39K
-1.47M
302.04K
1.12M
-17.25K
Gain on sale of security
--1.42M
--0
----
--302.04K
--1.12M
----
----
----
----
----
Other non- operating income (expenses)
-8,437.62%-1.47M
----
----
----
--1.12M
---17.25K
----
----
----
----
Income before tax
-223.70%-28.75M
-350.01%-13.46M
-139.27%-6.88M
-191.28%-4.54M
-165.72%-3.88M
-14.01%-8.88M
-104.24%-2.99M
-45.58%-2.88M
37.83%-1.56M
21.01%-1.46M
Income tax
Net income
-223.70%-28.75M
-350.01%-13.46M
-139.27%-6.88M
-191.28%-4.54M
-165.72%-3.88M
-14.01%-8.88M
-104.24%-2.99M
-45.58%-2.88M
37.83%-1.56M
21.01%-1.46M
Net income continuous Operations
-223.70%-28.75M
-350.01%-13.46M
-139.27%-6.88M
-191.28%-4.54M
-165.72%-3.88M
-14.01%-8.88M
-104.24%-2.99M
-45.58%-2.88M
37.83%-1.56M
21.01%-1.46M
Minority interest income
Net income attributable to the parent company
-223.70%-28.75M
-350.01%-13.46M
-139.27%-6.88M
-191.28%-4.54M
-165.72%-3.88M
-14.01%-8.88M
-104.24%-2.99M
-45.58%-2.88M
37.83%-1.56M
21.01%-1.46M
Preferred stock dividends
-75.00%31.25K
0
0.00%31.25K
Other preferred stock dividends
Net income attributable to common stockholders
-222.56%-28.75M
-350.01%-13.46M
-139.27%-6.88M
-191.28%-4.54M
-160.15%-3.88M
-12.60%-8.91M
-99.97%-2.99M
-43.31%-2.88M
38.59%-1.56M
20.66%-1.49M
Basic earnings per share
23.44%-0.98
-186.06%-0.41
-16.67%-0.21
26.92%-0.19
-148.79%-0.18
-233.04%-1.28
-97.37%-0.1433
46.25%-0.18
38.59%-0.26
22.77%-0.0724
Diluted earnings per share
23.44%-0.98
-186.06%-0.41
-16.67%-0.21
26.92%-0.19
-148.79%-0.18
-233.04%-1.28
-97.37%-0.1433
46.25%-0.18
38.59%-0.26
22.77%-0.0724
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 321.28%28.71M304.12%11.99M182.25%6.88M520.51%4.84M693.28%5M56.91%6.81M156.38%2.97M291.73%2.44M-48.54%779.8K-39.87%630.23K
Selling and administrative expenses 210.58%12.34M52.25%3.19M154.59%3.12M510.39%2.34M1,274.82%3.69M253.09%3.97M1,418.42%2.1M631.76%1.23M-26.65%383.23K-8.78%268.42K
-General and administrative expense 210.58%12.34M52.25%3.19M154.59%3.12M510.39%2.34M1,274.82%3.69M253.09%3.97M1,418.42%2.1M631.76%1.23M-26.65%383.23K-8.78%268.42K
Research and development costs 476.27%16.36M910.57%8.8M210.30%3.76M530.28%2.5M261.84%1.31M-11.75%2.84M-14.58%870.47K166.27%1.21M-60.06%396.57K-52.00%361.81K
Operating profit -321.28%-28.71M-304.12%-11.99M-182.25%-6.88M-520.51%-4.84M-693.28%-5M-56.91%-6.81M-156.38%-2.97M-291.73%-2.44M48.54%-779.8K39.87%-630.23K
Net non-operating interest income expense 100.01%249100.71%54100.01%65100.01%64100.01%6640.51%-2.05M97.54%-7.56K67.63%-437.84K21.42%-777.68K-3.73%-828.76K
Non-operating interest income --2495,500.00%54--656,300.00%64--66--0---1--0--1--0
Non-operating interest expense --0--0--0--0--0-40.51%2.05M-97.54%7.56K-67.63%437.84K-21.42%777.68K3.73%828.76K
Other net income (expense) -180.48%-48.39K-1.47M302.04K1.12M-17.25K
Gain on sale of security --1.42M--0------302.04K--1.12M--------------------
Other non- operating income (expenses) -8,437.62%-1.47M--------------1.12M---17.25K----------------
Income before tax -223.70%-28.75M-350.01%-13.46M-139.27%-6.88M-191.28%-4.54M-165.72%-3.88M-14.01%-8.88M-104.24%-2.99M-45.58%-2.88M37.83%-1.56M21.01%-1.46M
Income tax
Net income -223.70%-28.75M-350.01%-13.46M-139.27%-6.88M-191.28%-4.54M-165.72%-3.88M-14.01%-8.88M-104.24%-2.99M-45.58%-2.88M37.83%-1.56M21.01%-1.46M
Net income continuous Operations -223.70%-28.75M-350.01%-13.46M-139.27%-6.88M-191.28%-4.54M-165.72%-3.88M-14.01%-8.88M-104.24%-2.99M-45.58%-2.88M37.83%-1.56M21.01%-1.46M
Minority interest income
Net income attributable to the parent company -223.70%-28.75M-350.01%-13.46M-139.27%-6.88M-191.28%-4.54M-165.72%-3.88M-14.01%-8.88M-104.24%-2.99M-45.58%-2.88M37.83%-1.56M21.01%-1.46M
Preferred stock dividends -75.00%31.25K00.00%31.25K
Other preferred stock dividends
Net income attributable to common stockholders -222.56%-28.75M-350.01%-13.46M-139.27%-6.88M-191.28%-4.54M-160.15%-3.88M-12.60%-8.91M-99.97%-2.99M-43.31%-2.88M38.59%-1.56M20.66%-1.49M
Basic earnings per share 23.44%-0.98-186.06%-0.41-16.67%-0.2126.92%-0.19-148.79%-0.18-233.04%-1.28-97.37%-0.143346.25%-0.1838.59%-0.2622.77%-0.0724
Diluted earnings per share 23.44%-0.98-186.06%-0.41-16.67%-0.2126.92%-0.19-148.79%-0.18-233.04%-1.28-97.37%-0.143346.25%-0.1838.59%-0.2622.77%-0.0724
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -